Clara Yuri Kim
Overview
Explore the profile of Clara Yuri Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oh J, Kim C, Jeong D, Kim Y, Kim M, Cho J
Int J Biol Sci
. 2024 Feb;
20(3):1045-1063.
PMID: 38322121
Homeobox genes and their encoded DNA-binding homeoproteins are master regulators of development. Consequently, these homeotic elements may regulate key steps in cancer pathogenesis. Here, using a combination of analyses of...
2.
Kim C, Kim Y, Oh J, Kim M
Anticancer Res
. 2021 Jul;
41(7):3409-3417.
PMID: 34230136
Background/aim: ER-positive breast cancer patients commonly undergo endocrine therapy with drugs such as tamoxifen. Despite tamoxifen being a highly effective drug, long-term treatment results in resistance in one-third of the...
3.
Kim Y, Kim C, Oh J, Kim M
Cells
. 2021 Jul;
10(7).
PMID: 34209871
Endocrine therapy is used to treat estrogen receptor (ER)-positive breast cancer. Tamoxifen is effective against this cancer subtype. Nonetheless, approximately 30% of patients treated with tamoxifen acquire resistance, resulting in...
4.
Kim C, Kim Y, Oh J, Kim M
J Cancer
. 2021 Jun;
12(15):4626-4637.
PMID: 34149926
Tamoxifen is a commonly used drug to treat estrogen receptor-positive patients with breast cancer. Despite the outstanding efficacy of tamoxifen, approximately one-third of patients develop resistance toward it, thereby presenting...
5.
Oh J, Lee J, Kim K, Kim C, Jeong D, Cho Y, et al.
Cancer Lett
. 2020 Sep;
495:145-155.
PMID: 32987137
Approximately 70% of breast cancers are estrogen receptor (ER)-positive and treated with endocrine therapy. A commonly used treatment agent, tamoxifen, shows high efficacy for improving prognosis. However, approximately one-third of...
6.
Kim C, Oh J, Lee J, Kim M
J Cancer
. 2020 Apr;
11(12):3416-3423.
PMID: 32284737
Breast cancer is one of the most commonly diagnosed cancers in women worldwide. Approximately 40% of patients with breast cancer acquire endocrine resistance following therapy with tamoxifen. Many explanations for...
7.
Oh J, Kim C, Lee J, Kim M
Acta Biochim Biophys Sin (Shanghai)
. 2018 Apr;
50(6):555-559.
PMID: 29688244
During the development of an embryo, the initiation of the collinear expression of Hox genes is essential for the proper formation of the anteroposterior body axis. Retinoic acid (RA), a...
8.
Lee J, Mustafa M, Kim C, Kim M
J Cancer
. 2017 Aug;
8(11):2124-2131.
PMID: 28819414
CCCTC-binding factor (CTCF), a ubiquitous 11-zinc finger multifunctional protein, has distinct molecular functions, such as transcriptional activation, repression, and chromatin barrier activity, in a locus-specific manner. Elevated CTCF levels in...
9.
Lee J, Yun H, Kim C, Cho Y, Lee Y, Kim M
Dev Growth Differ
. 2017 Jul;
59(6):515-525.
PMID: 28707738
Prenatal stress during pregnancy leads to sex-specific effects on fetal development and disease susceptibility over the life span; however, the origin of sex differences has not been identified. The placenta...
10.
Heitjan D, Kim C, Li H
Stat Med
. 2004 Apr;
23(8):1297-309.
PMID: 15083484
We describe a Bayesian methodology for estimating the cost-effectiveness of a new treatment compared to a standard in a clinical trial, when censoring of survival, the effectiveness variable, induces censoring...